Search results
Results From The WOW.Com Content Network
COVID-19 vaccine vials being made ready for delivery at a vaccination centre in Mexico By September 25, 2021, Mexico had administered a total of 97,523,789 doses (74.87 vaccine doses per 100 people), with 54,275,054 residents having received at least one dose and 43,248,659 residents fully vaccinated. [ 1 ]
MEXICO CITY (Reuters) -Mexican President Andres Manuel Lopez Obrador said on Friday the United States would probably send his country 5 million more doses of AstraZeneca's COVID-19 vaccine, as the ...
President Andrés Manuel López Obrador said Sunday that his government has agreed with a U.N. proposal to delay shipments of the Pfizer coronavirus vaccine to countries like Mexico that had ...
Mexican President Andres Manuel Lopez Obrador said on Friday the United States would probably send Mexico around 5 million more doses of the AstraZeneca COVID-19 vaccine, saying a factory set to ...
In Mexico, 4% of individuals received at least one dose of the COVID-19 vaccine as of March 2021. [2] Wealthy Mexicans were reported to travel to the neighboring United States for receiving their vaccinations. [2] In March, the White House announced that four million doses of COVID-19 vaccines manufactured in the United States will be sent to ...
On July 31, 2013, the Uruguayan House of Representatives approved a bill to legalize the production, distribution, sale, and consumption of marijuana by a vote of 50 to 46. Relating this vote to the 2012 legalization of marijuana by the U.S. states Colorado and Washington, John Walsh, drug policy expert of the Washington Office on Latin America ...
The United States plans to send roughly 4 million doses of AstraZeneca's COVID-19 vaccine that it is not using to Mexico and Canada in loan deals with the two countries, yielding to requests to ...
In February 2021, data released from an interim analysis of Phase III trials with 30,000 participants and 101 COVID cases showed that globally, the vaccine administered as an intramuscular injection had an efficacy of 65.7% at preventing moderate cases of COVID-19 and 90.98% efficacy at preventing severe cases. In the Pakistan trial subset, the ...